Hindustan Bio Sciences Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 3.693 million compared to INR 3.750 million a year ago. Loss before exceptional & extraordinary items and tax was INR 0.071 million compared to INR 1.037 million a year ago. Loss before tax was INR 0.071 million compared to INR 1.037 million a year ago. Net loss was INR 0.071 million compared to INR 1.037 million a year ago. Basic and diluted loss per share was INR 0.01 against INR 0.10 a year ago. For the nine months, the company reported revenue from operations of INR 4.429 million compared to INR 7.100 million a year ago. Loss before exceptional & extraordinary items and tax was INR 1.848 million compared to INR 3.308 million a year ago. Loss from ordinary activities before tax was INR 1.848 million compared to INR 3.308 million a year ago. Net loss from ordinary activities after tax was INR 1.848 million compared to INR 3.308 million a year ago. Basic and diluted loss per share was INR 0.18 against INR 0.32 a year ago.